All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
The recommended flu vaccine by the FDA advisory committee uses the same mRNA technology that helped develop the COVID-19 vaccine.
Visoot Uthairam/Moment RF/Getty Images
hide caption
toggle caption
Visoot Uthairam/Moment RF/Getty Images
FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.
Moderna flu vaccine wins unanimous support from FDA panel
FDA panel recommends Moderna’s mRNA flu shot for older adults
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR
FDA Staff Weighs In on Potential First mRNA Flu Shot
New mRNA flu vaccine faces scrutiny ahead of key FDA decision
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up
The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to…
The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still…
U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to…
Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.
Moderna's novel vaccine was at the center of dustup with agency earlier this year
